Enteric-coated mycophenolate sodium (EC-MPS) in de novo heart transplant patients: Pharmacokinetic (PK) results.

被引：0
|
作者：
Sechaud, R
Yeh, CM
Balez, S
Koelle, E
Hummel, M
Gerosa, G
Yonan, N
Ross, H
Miller, LW
Brambilla, R
机构：
[1] Novartis Pharma AG, Basel, Switzerland
[2] Deutsch Herzzentrum, Berlin, Germany
[3] Chirurg Cardiovasc, Padua, Italy
[4] Wythenshawe Hosp, Manchester M23 9LT, Lancs, England
[5] Toronto Hosp, Toronto, ON M5T 2S8, Canada
[6] Univ Minnesota Hosp, Minneapolis, MN USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2005年 / 5卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
373
引用
收藏
页码：250 / 250
页数：1
相关论文
共 50 条
  • [1] Enteric-coated mycophenolate sodium (EC-MPS) is comparable to mycophenolate mofetil in de novo heart transplant patients. Twelve months efficacy and safety results.
    Kobashigawa, JA
    Gerosa, G
    Caforio, A
    Renlund, DG
    Ross, H
    Yonan, N
    Hummel, M
    Segovia, J
    Almenar, L
    Brambilla, R
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 244 - 244
  • [2] Enteric-coated mycophenolate sodium (EC-MPS) vs mycophenolate mofetil (MMF) in de novo heart transplant patients: 6-month efficacy and safety results.
    Kobashigawa, JA
    Davis, SF
    Renlund, DG
    Eisen, H
    Miller, L
    Lehmkuhl, H
    Gambino, A
    Brambilla, R
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 281 - 281
  • [3] Twelve months results of enteric-coated mycophenolate sodium (EC-MPS) in de novo heart transplant patients showed excellent efficacy and safety
    Kobashigawa, J. A.
    Renlund, D. G.
    Gerosa, G.
    Caforio, A.
    Ross, H.
    Lehmkuhl, H. B.
    Eisen, H.
    Segovia, J.
    Brambilla, R.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (02): : S166 - S166
  • [4] USE OF ENTERIC-COATED MYCOPHENOLATE SODIUM (EC-MPS) IN LIVER TRANSPLANT PATIENTS
    de Vera, Michael E.
    Lopez, Roberto
    Yelochan, Barbara
    Hope, Laurie
    Marcos, Amadeo
    Fontes, Paulo
    [J]. LIVER TRANSPLANTATION, 2008, 14 (07) : S112 - S112
  • [5] Pharmacokinetics (PK) of enteric-coated mycophenolate sodium (EC-MPS, Myfortic®) in stable renal transplant patients with Neoral® or Tacrolimus.
    Kaplan, B
    Meier-Kriesche, HU
    Minnick, P
    Bastien, MC
    Sechaud, R
    Yeh, CM
    Balez, S
    Picard, F
    Schmouder, R
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 910A - 910A
  • [6] ENTERIC-COATED MYCOPHENOLATE SODIUM (EC-MPS, MYFORTIC): LONG TERM ADMINISTRATION IS SAFE IN KIDNEY TRANSPLANT PATIENTS
    Salvadori, Maurizio
    [J]. NEPHROLOGY, 2005, 10 : A213 - A214
  • [7] 12 MONTH FOLLOW UP RESULTS OF AN INITIAL INTENSIFIED DOSING REGIMEN OF ENTERIC-COATED MYCOPHENOLATE SODIUM (EC-MPS) IN DE NOVO RENAL TRANSPLANT RECIPIENTS
    Arns, W.
    Kuypers, D.
    Tedesco Silva, H.
    Budde, K.
    Shoker, A.
    Prestele, H.
    [J]. TRANSPLANT INTERNATIONAL, 2011, 24 : 81 - 82
  • [8] Pilot Study To Evaluate the Efficacy and Safety of Enteric-Coated Mycophenolate Sodium (EC-MPS) in Combination with Sirolimus in De Novo Renal Transplant Recipients
    Peddi, V. R.
    Wilson, J.
    Mena, N.
    Lu, L.
    Miguel, M.
    Ueda, K.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 412 - 412
  • [9] Pharmacokinetic and pharmacodynamic comparison of mycophenolate mofetil (MMF) and enteric-coated mycophenolate-sodium (EC-MPS) in maintenance renal transplant patients on tacrolimus.
    Budde, K
    Neumayer, HH
    Grohmann, J
    Waiser, J
    Hambach, P
    Bauer, S
    Mai, I
    Sandau, K
    Fischer, W
    Hepburn, H
    Glander, P
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 191 - 191
  • [10] LONG-TERM SAFETY OF ENTERIC-COATED MYCOPHENOLATE SODIUM (EC-MPS) IN RENAL TRANSPLANT RECIPIENTS
    Neumayer, Hans H.
    [J]. NEPHROLOGY, 2005, 10 : A213 - A213
12345